Tissue blood flow and oxygen transport in critically ill patients.
The theoretical and practical solutions to the problems of increasing oxygen transport are well understood. Unfortunately the quantitation of hypoxia, both as an absolute deficit and as a precise method of prognosis is not yet available. This may well be because regional hypoxia in a vital tissue cannot be mirrored in a total body measurement. In the low-flow state, oxygen delivery can be maintained by redistribution of cardiac output, reduction of oxygen uptake by ischemic tissue by reducing work load, by increasing oxygenation of the blood, or by decreasing the affinity of oxygen for hemoglobin. The latter provides for more oxygen to be delivered by a given amount of oxyhemoglobin before the tension falls to deleterious regions (about 20 torr). There is some evidence that pharmacologic doses of methylprednisolone may be beneficial in this respect.
D001775:Blood Circulation; D002302:Cardiac Output; D006801:Humans; D000860:Hypoxia / Q000503:physiopathology* / Q000628:therapy; D009203:Myocardial Infarction / Q000188:drug therapy; D010100:Oxygen / Q000097:blood*; D010102:Oxygen Inhalation Therapy; D010108:Oxyhemoglobins / Q000032:analysis; D011433:Propranolol / Q000627:therapeutic use; D012769:Shock / Q000503:physiopathology* / Q000628:therapy; D013256:Steroids / Q000627:therapeutic use
D010108:Oxyhemoglobins; D013256:Steroids; D011433:Propranolol; D010100:Oxygen